Millennium Pharmacon Valuation

SDPC Stock  IDR 144.00  1.00  0.69%   
At this time, the firm appears to be overvalued. Millennium Pharmacon secures a last-minute Real Value of 125.16 per share. The latest price of the firm is 144.0. Our model forecasts the value of Millennium Pharmacon from analyzing the firm fundamentals such as Return On Equity of 0.0938, profit margin of 0.01 %, and Current Valuation of 828.27 B as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend picking up undervalued stocks and discarding overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
144.00
Please note that Millennium Pharmacon's price fluctuation is very steady at this time. Calculation of the real value of Millennium Pharmacon is based on 3 months time horizon. Increasing Millennium Pharmacon's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Millennium Pharmacon International is useful when determining the fair value of the Millennium stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Millennium Pharmacon. Since Millennium Pharmacon is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Millennium Stock. However, Millennium Pharmacon's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  144.0 Real  125.16 Hype  144.0 Naive  143.52
The real value of a stock, also known as the intrinsic value, is the underlying worth of a company that is reflected in its stock price. It is based on the company's financial performance, assets, liabilities, growth prospects, management team, industry conditions, and other relevant factors. The real value of a stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, price-to-book ratio, and other valuation metrics. The real value of a stock may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence the stock's price. It is important to note that the real value of a stock is not a fixed number and may change over time based on changes in the company's performance and other relevant factors.
123.77
Downside
125.16
Real Value
158.40
Upside
Estimating the potential upside or downside of Millennium Pharmacon International helps investors to forecast how Millennium stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Millennium Pharmacon more accurately as focusing exclusively on Millennium Pharmacon's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
139.95148.70157.45
Details
Hype
Prediction
LowEstimatedHigh
142.61144.00145.39
Details
Naive
Forecast
LowNext ValueHigh
142.14143.52144.91
Details

Millennium Pharmacon Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Millennium Pharmacon's current stock value. Our valuation model uses many indicators to compare Millennium Pharmacon value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Millennium Pharmacon competition to find correlations between indicators driving Millennium Pharmacon's intrinsic value. More Info.
Millennium Pharmacon International is currently regarded as top stock in price to book category among related companies. It is currently regarded as top stock in beta category among related companies totaling about  0.64  of Beta per Price To Book. The ratio of Price To Book to Beta for Millennium Pharmacon International is roughly  1.56 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Millennium Pharmacon by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Millennium Pharmacon's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Millennium Pharmacon's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Millennium Pharmacon's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Millennium Pharmacon and how it compares across the competition.

About Millennium Pharmacon Valuation

The stock valuation mechanism determines the current worth of Millennium Pharmacon International on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Millennium Pharmacon International. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Millennium Pharmacon based exclusively on its fundamental and basic technical indicators. By analyzing Millennium Pharmacon's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Millennium Pharmacon's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Millennium Pharmacon. We calculate exposure to Millennium Pharmacon's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Millennium Pharmacon's related companies.
PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, food supplements, and medical devices. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Millennium Pharmacon operates under Medical Distribution classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1092 people.

8 Steps to conduct Millennium Pharmacon's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Millennium Pharmacon's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Millennium Pharmacon's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Millennium Pharmacon's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Millennium Pharmacon's revenue streams: Identify Millennium Pharmacon's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Millennium Pharmacon's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Millennium Pharmacon's growth potential: Evaluate Millennium Pharmacon's management, business model, and growth potential.
  • Determine Millennium Pharmacon's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Millennium Pharmacon's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Millennium Pharmacon International. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Millennium Stock analysis

When running Millennium Pharmacon's price analysis, check to measure Millennium Pharmacon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Millennium Pharmacon is operating at the current time. Most of Millennium Pharmacon's value examination focuses on studying past and present price action to predict the probability of Millennium Pharmacon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Millennium Pharmacon's price. Additionally, you may evaluate how the addition of Millennium Pharmacon to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Please note, there is a significant difference between Millennium Pharmacon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Millennium Pharmacon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Millennium Pharmacon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.